Early outcomes of minimally invasive surgery versus thoracotomy for non-small cell lung cancer patients with neoadjuvant immunochemotherapy: a multi-center propensity score- matched study
Hanbo Pan,
Hang Chen,
Zhen Ge
et al.
Abstract:Background
Neoadjuvant immunochemotherapy has revolutionized the treatment of non-small lung cancer (NSCLC) but may notably escalate the surgery’s intricacy. Consequently, the sufficiency of minimally invasive surgery (MIS) remains controversial. This study aims to assess the safety and feasibility of MIS for NSCLC patients after induction immunochemotherapy.
Methods
NSCLC patients with neoadjuvant immunochemotherapy who underwent MIS or open lobectomy at six institutions from 2019 to 2023 were retrospective… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.